Pharma
Trevia (Sitagliptin Tablets USP 50 mg)
DPP-4 inhibitor; 50 mg Sitagliptin tablets for the management of Type 2 Diabetes.
Trevia (Sitagliptin Tablets USP 50 mg)
Trevia contains Sitagliptin, an orally-active dipeptidyl peptidase-4 (DPP-4) inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus. It works by increasing the levels of natural substances called incretins, which help control blood sugar by increasing insulin release, especially after a meal, and decreasing the amount of sugar made by the liver. It is typically used as an adjunct to diet and exercise. Trevia is not for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. Common side effects may include upper respiratory tract infection, nasopharyngitis, and headache.
You May Also Like
Antihypertensive and alpha-2 agonist; 0.1 mg tablets for blood pressure and ADHD management.
Combination antidiabetic agent; 2.5 mg Linagliptin and 1000 mg Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/850 mg Sitagliptin/Metformin tablets for Type 2 Diabetes.
High-strength immunosuppressant; 100 mg Cyclosporine soft gelatin capsules for transplant maintenance.